Canopy Growth (CGC) EBT Margin Growth (1y) (2020 - 2026)
Canopy Growth (CGC) EBT Margin Growth (1y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -1,585.00 |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -177.00 |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -27.00 |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | -356.00 |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 436.00 |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | -629.00 |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 208.00 |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Canopy Growth | 445.49 Mn | 198.48 Mn | 16.08 Mn | 3,557.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3,557.00 |
| Dec 31, 2025 | 8,048.00 |
| Sep 30, 2025 | 17,053.00 |
| Jun 30, 2025 | 9,186.00 |
| Dec 31, 2024 | 14,974.00 |
| Sep 30, 2024 | 442.00 |
| Jun 30, 2024 | -14,244.00 |
| Mar 31, 2024 | 31,075.00 |
| Dec 31, 2023 | -1,160.00 |
| Sep 30, 2023 | 3,197.00 |
| Jun 30, 2023 | 174,833.00 |
| Mar 31, 2023 | -67,154.00 |
| Dec 31, 2022 | -19,430.00 |
| Sep 30, 2022 | -19,919.00 |
| Jun 30, 2022 | -204,797.00 |
| Mar 31, 2022 | 51,470.00 |
| Dec 31, 2021 | 478,671.00 |
| Sep 30, 2021 | 5,610.00 |
| Jun 30, 2021 | 39,873.00 |
| Mar 31, 2021 | 95,746.00 |